Finerenone may lower risks for kidney and cardiovascular events for adults with chronic kidney disease and type 2 diabetes, ...

Dr Joseph A Hill discusses the diagnosis and management of heart failure with preserved ejection fraction (HFpEF).

A cardiologist reveals a surprising, often overlooked cause of heart failure that’s missed during check-ups, but early detection can make all the difference.

Patients with type 2 diabetes mellitus are at a higher risk of developing heart failure compared with the healthy population. In recent landmark clinical trials, sodium-glucose co-transporter 2 (SGLT2 ...

The Weight–Heart Failure Connection Heart failure is the organ’s inability to keep up efficiently with the demands placed on it. And it’s becoming more and more common, Ndumele says. “Lots of factors ...

There are consistent associations between elevated urinary metal levels and increased HF risk over time across geographically diverse cohorts of adults.

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Aims We conducted a meta-analysis of randomised controlled trials (RCTs) of implantable haemodynamic monitoring (IHM)-guided care. Methods PubMed and Ovid MEDLINE were searched for RCTs of IHM in ...

Review question We reviewed existing evidence on the treatment with different agents, which act by either increasing the ability of the heart to contract (inotropic drugs) or by expansion of the blood ...

Human heart failure is a disease with multifactorial causes, considerable morbidity, and high mortality. Several circulating autoantibodies, some of them being heart-specific, play a crucial role in ...

This review addresses open questions about the role of β-adrenergic receptors in cardiac function and failure. Cardiomyocytes express all three β-adrenergic receptor subtypes—β1, β2, and, at least in ...